The content on this page is designed for Australia. Check courses designed for Canada (EN)

This course has expired. View available courses.

Geriatrics, Cardiology

Interactive Case Studies in Anticoagulants: The role of DOACs in managing AF in patients with complex comorbidities

Atrial fibrillation (AF) is the most common recurrent arrhythmia in clinical practice and the prevalence increases steeply with age, and with common age-associated co-morbidities such as heart failure, coronary artery disease, obesity, hypertension, diabetes and chronic kidney disease. It is associated with increased risk of serious morbidities such as stroke and with death.

Current clinical guidelines recommend direct oral anticoagulants (DOACs) as the treatment of choice to reduce stroke risk in non-valvular AF (NVAF). It is important for clinicians to be confident prescribing these drugs in the spectrum of patients with NVAF.

This program will help improve your skills and knowledge when prescribing DOACs for complex older patients with NVAF in the presence of co-morbidities and polypharmacy, while taking into account and mitigating important risks, such as bleeding and considering appropriate drug selection and dose adjustment.


This program is supported by an independent and unrestricted educational grant by BMS Alliance & Pfizer.

DURATION

35 min.

PROFESSION

Physician, Specialist

# OF CREDITS

0

ACCREDITATION

Unaccredited

EXPIRY DATE

2023-01-28

Atrial fibrillation (AF) is the most common recurrent arrhythmia in clinical practice and the prevalence increases steeply with age, and with common age-associated co-morbidities such as heart failure, coronary artery disease, obesity, hypertension, diabetes and chronic kidney disease. It is associated with increased risk of serious morbidities such as stroke and with death.

Current clinical guidelines recommend direct oral anticoagulants (DOACs) as the treatment of choice to reduce stroke risk in non-valvular AF (NVAF). It is important for clinicians to be confident prescribing these drugs in the spectrum of patients with NVAF.

This program will help improve your skills and knowledge when prescribing DOACs for complex older patients with NVAF in the presence of co-morbidities and polypharmacy, while taking into account and mitigating important risks, such as bleeding and considering appropriate drug selection and dose adjustment.


This program is supported by an independent and unrestricted educational grant by BMS Alliance & Pfizer.

Faculty

Professor Andrew Sindone, B.Med (Hons), MD (UNSW), FRACP, FCSANZ, FNHFA
Director Heart Failure Unit and
Department of Cardiac Rehabilitation Concord Hospital and
Head of Department of Cardiology, Ryde Hospital

A/Prof Charles Denaro, MBBS (1st Class hons), FRACP, MD (Research) PSM
Director, Department of Internal Medicine & Aged Care
Royal Brisbane & Women's Hospital
Associate Professor of Medicine, University of Queensland

Dr Maria Dellamalva, MBBS FRACP
Royal Adelaide Hospital and Memorial Medical Centre and
Senior Clinical Lecturer University of Adelaide

Learning objectives

Upon completion of this continuing education program clinicians will be better able to:

  • Manage complex, older patients with NVAF and multiple co-morbidities and polypharmacy, in accordance with current clinical guidelines
  • Prescribe DOACs appropriately for patients with NVAF, including drug selection and dose adjustment in accordance with patient factors such as age, weight, renal function and bleeding risk
Cost of course:  
Free
# of credits: 0
Duration: 35 min.

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.